Rheumatology 2023 | Paris | France | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Current trends in Rheumatology, Orthopedics, and Arthroplasty

- Rheumatology 2023

About

On behalf of our Allied Academies family and conference committee, we are excited to begin our second series of the conference, titled "18th International Meeting on Rheumatology and Orthopedics Society" which will take place in Paris, France on October 09-11, 2023..

"Current Trends in Rheumatology, Orthopedics, and Arthroplasty" is the theme of the 18th International Meeting on Rheumatology and Orthopedics Society. Honorable Orthopedic Surgeons, Rheumatologists and other associated specialists, Medical Students, Research Scholars, Young Researchers, Associations, Health Professionals, and collaborators are all invited to our Rheumatology 2023 conference.

Rheumatology 2023 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc.

Aim & Scope

Researchers and Professors can share their Speaker Presentations, Poster Presentations, and Host the International Conference as a Team at the Rheumatology 2023 Conference.

Association Partnership, Collaboration with our International events as Committee Members, Speakers, and Delegates, Academic collaborations, and Group Participation are all opportunities provided by the Organizing Committee to Universities, Associations, and Societies. Students and Research Scholars.

Our Conference Committee also allows business experts to share their valuable contributions as Plenary Speakers, Keynote Speakers, and Event Hosts, as wellas give networking opportunities, B2B Meetings, and Delegate involvement.

Audience Profile:

Rheumatology Health Professionals
Rheumatologist Directors and Chairpersons
Physiotherapists
Orthopedic Physicians & Surgeons
Orthopedic Research Fellows & Orthopedics Faculty
Health Care Professionals in Orthopedics and Rheumatology
Medical Students
Orthopedic Medical Colleges and Universities
Device Designers
Industrial Professionals
Physical Therapists
Training Institutes
Rheumatology & Orthopedics Research Institutes
Rheumatology & Orthopedics Societies
Rheumatology & Orthopedics Associations

Conference Highlights

Track 1

Rheumatology

Autoimmune/heritable
Basic science/genetics
Bone metabolism
Chr fatigue/fibromyalgia
Clinical pharmacology
Connective tissue Dz
Diagnostics/radiology
Gout and hyperuricemia
Pediatric rheumatology
Rheumatoid arthritis
Spondylarthropathies (SpA)
Systemic lupus (SLE)
Vasculitis syndromes
Gout
Podiatry
Fibromyalgia
Polyarthralgia
Polymyalgia Rheumatica
Sjogren ’s syndrome
Lyme disease
Scleroderma
Tendinitis & Bursitis
Spinal Disorders

Track 2

Orthopedics

Orthopedic surgery for children
Surgery on the hips and knees
Surgery on the feet and ankles
Surgical procedures for the spine and research
Orthopedic oncology
Orthopedic trauma
Surgical sports medicine
Prosthetics and orthotics

Track 3

Arthritis

Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis and Spondyloarthropathies
Osteoarthritis
Osteoporosis

Track 4

Arthroscopy

Arthroscopy in the upper extremity

Long term prognosis of intraarticular knee injuries
Scaphoid Fractures - epidemiology, diagnosis and treatment
Predictors of Complications after Anterior Cruciate Ligament Injury
Clinical and radiographic outcome of meniscectomy and meniscus repair in the stable knee

Track 5

Arthroplasty

Shoulder arthroplasty

Total knee arthroplasty
hip arthroplasty
Arthroplasty preparation
Recovery after arthroplasty

Track 6

Physiotherapy

Neuromusculoskeletal - lowback pain, sub acromial impingement, sports injuries i.e., ACL rupture, osteoarthritis, tennis' elbow
Neurological - stroke, spinal cord injuries, Parkinson's, multiple sclerosis
Cardiovascular - chronic heart disease, rehabilitation after heart attack
Respiratory - asthma, chronic obstructive pulmonary disease, cystic fibrosis

Track 7

Rehabilitation

Prosthetic and amputee rehabilitation
Movement disorder rehabilitation
Pediatric rehabilitation
Covid-19 & Post-Acute Rehabilitation
Cancer rehabilitation
Latest technology in rehabilitation
Physiotherapy & Rehabilitation

Track 8

Plastic Surgery

Reconstructive Surgery

Aesthetic surgery

Craniofacial Surgery

Features of Rheumatology 2023

Meet visionaries from academia and industry to be inspired at Rheumatology 2023.
Increase your knowledge and problem-solving abilities.
Knowledge, benchmarking, and networking are all available in one location.
Make connections and network on a global scale.
Scientific plans that are well-organized and structured
Poster presentations and world-class displays are available.
Stalwarts from several worldwide societies are expected to attend.
Speakers and scientists from throughout the world will be represented.
Early-career researchers and students receive career advice.
Deliberations and conversations in the scientific community are fascinating
The ideal platform for international networking

The Most Important Reasons to Attend Rheumatology 2023

Boost your network's effectiveness.
A fantastic opportunity to participate in a global expert gathering
Obtain a specific area of expertise
Make a name for yourself as an expert.
Investigate New Concepts & Share your thoughts.
Obtain new sponsorships and collaborations
Share your most recent findings and breakthroughs.
With your friends and family, go on an adventure in Dubai.

Market Analysis

Global Rheumatology Market

Market for Rheumatology 2023 Worldwide By drug class (disease-modifying anti-rheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and drugs for uric acid), disease indication (psoriatic arthritis, gout, osteoarthritis, and ankylosing spondylitis), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and country (the United States, Canada, Mexico, Germany, Italy, the United Kingdom, France

In the projection period of 2021 to 2028, the rheumatic market is anticipated to develop at a CAGR of 2.23% and is projected to reach USD 39,463.29 million by 2028. The rheumatic therapeutics market report from Data Bridge Market Research offers analysis and insights into the numerous elements that are anticipated to be present over the course. The market for rheumatic treatments is expanding at an accelerated rate due to the rise in rheumatoid arthritis 2023 prevalence.

The rise in use of disease-modifying anti-rheumatic medicines (DMARDs) for the treatment of the relevant disease and the increased knowledge of early identification and treatment of rheumatology disease symptoms are the main factors propelling the growth of the rheumatology therapeutics market. Rheumatic disorders are becoming more common, fitness is becoming more popular around the world, and biopharmaceuticals are becoming more widely accepted, all of which are driving the growth of the rheumatology therapeutics market. The market for rheumatic medicines is further impacted by the growing number of small molecules in the drug development pipeline because they are known to be less expensive than biologics. Additionally, the market for rheumatic treatments 2023 is favorably impacted by the rise in geriatric population, technical developments in the pharmaceutical business, rising investments in the healthcare sector, and spike in healthcare spending among the middle class. Additionally, in the projection period of 2021 to 2028, the rate of new biologic drug launches is expected to increase, along with approvals and the penetration of generic pharmaceuticals. These factors offer lucrative prospects to companies in the rheumatic therapeutics market.

The Middle East foot and ankle devices market is divided into different categories based on the kind of product, process, application, end user, competitive environment, and geographic distribution. The market is segmented into joint implants, fixation devices, soft tissue orthopedic devices 2023, bracing & support devices, and prostheses based on the kind of product. A growing senior population and an increase in adult accidental falls are expected to cause the joint implants sector to dominate the Middle East market for foot and ankle devices.

Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Arthrex, CONMED Corporation, Orthofix Medical, and Ottobock are among the companies competing in the Middle East foot and ankle devices market.

Rheumatology Market - UAE:

During the forecast period, the market for artificial organs and bionic implants in the UAE is anticipated to expand at a CAGR of 11.48%. As the prevalence of chronic diseases 2023 rises, lifestyle problems such improper eating patterns, smoking, drinking, and inactivity—which are the main factors fueling the market growth—can cause organ malfunction. For instance, a July 2020 article titled "Management of nonalcoholic fatty liver disease in the Middle East" predicted that by 2030, 372,000 persons in the United Arab Emirates would have nonalcoholic fatty liver disease (NAFLD). Additionally, according to the same report, the UAE's NAFLD prevalence was predicted to increase by 87% by 2030.

Lower back and neck pain ranked second and sixth, respectively, among musculoskeletal pains in 2017, increasing by 120 percent and 144.7 percent from 2007. Musculoskeletal disorders were treated in 11 out of 54 hospitals in Abu Dhabi, an emirate of the United Arab Emirates, as one of the top five services for patients who were hospitalized in 2017.

In a different emirate called Dubai, the orthopedics 2023 department was visited by 9% of outpatients at private hospitals. Based on the number of outpatients/inpatients, prevalence, and average cost per treatment, the orthopedic surgery market in the UAE was predicted to be worth $300-350 million in 2015. Emirati patients with musculoskeletal disorders are anticipated to rise as the population grows, but there will certainly be a shortage of hospital beds.

Of the 371 rheumatologists in Dubai that participated in the survey, 132 finished it. AxSpA patient referrals to their clinic were delayed for the most part (88%) of the respondents, with the primary cause being a "lack of illness awareness by primary care physicians" (56%). According to the survey participants, "lack of awareness of long-term complications of spondyloarthritis" (34%), and "some non-rheumatology specialists think they can treat and diagnose AxSpA.

The greatest challenge, according to two-thirds of survey respondents (66%) was dealing with "patients who present with atypical symptoms such as: 3 months back pain, chronic back pain occurring >45 years of age, or chronic back pain with 1 spondyloarthritis features but without sacroiliitis on imaging" (51% of respondents who stated they had a challenge). Patients cannot get the medication because it is not accessible at my hospital/clinic pharmacy, according to 31% of patients, and patients may be afraid of drug adverse effects, according to 39.6% of patients, were the two primary patient-related difficulties to managing AxSpA. The vast majority of research participants were educated, although they are fully aware of RMDs. People with diagnosed rheumatic illnesses and patients who underwent screening had the same understanding of RMDs. Responses to questions about whether rheumatic autoimmune diseases can be treated and how long treatment should last for people with established rheumatic autoimmune disorders varied significantly by education level. The likelihood of silent autoimmune thyroid illness is higher in RA patients who have had symptoms for longer than a year compared to age- and gender-matched RA patients who have only recently developed symptoms. Regular evaluation of thyroid function may be a crucial component of the standard biochemical and immunological RA screening. Fight back more tenaciously the more the sickness tries to paralyses you.

allied